Monday, 28 September 2026 Every NSE & BSE announcement, by company

ALFA Filings Every announcement, straight from the exchange

Medicamen Biotech Ltd

NSE: MEDICAMEQ · BSE: 531146 · Pharmaceuticals & Biotechnology · 5 announcements

Share price: ₹315.30
Market cap: ₹427.7 Cr
Revenue (annual): ₹197.8 Cr
Net profit (annual): ₹9.64 Cr
P/E (TTM): 39.5×Sector 50.4×
Promoter holding: 40.46%+0.00% QoQ
FII holding: 0.07%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 3 Annual General Meeting 2

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

14 Aug 2026 16:11 IST NSE

Financial Results

Medicamen Biotech Q1 FY27 Results: Net Profit ₹184.6 Cr, Up 15.3% YoY

Medicamen Biotech Ltd reported revenue from operations of ₹4,790 Cr (+11.3% YoY) and net profit of ₹184.6 Cr (+15.3% YoY) for Q1 FY27.

Key figure: Net profit ₹184.6 Cr · +15.3% YoY

Open full results → Read the filing ↗

14 Aug 2026 15:32 IST BSE

Financial Results

Medicamen Biotech Q1 FY27 Results: Net Profit ₹1.8 Cr, Up 12.5% YoY

Medicamen Biotech Ltd reported revenue from operations of ₹47.9 Cr (+11.4% YoY) and net profit of ₹1.8 Cr (+12.5% YoY) for Q1 FY27.

Key figure: Net profit ₹1.8 Cr · +12.5% YoY

Open full results → Read the filing ↗

27 May 2026 15:26 IST BSE

Financial Results

Medicamen Biotech Q4 FY26 Results: Net Profit ₹4.4 Cr, Up 131.6% YoY

Medicamen Biotech Ltd reported revenue from operations of ₹60.6 Cr (+104.7% YoY) and net profit of ₹4.4 Cr (+131.6% YoY) for Q4 FY26.

Key figure: Net profit ₹4.4 Cr · +131.6% YoY

Open full results → Read the filing ↗